IDXX - IDEXX Laboratories Inc. (IDXX) Q1 2024 Earnings Call Transcript
2024-05-01 12:25:23 ET
IDEXX Laboratories, Inc. (IDXX)
Q1 2024 Earnings Conference Call
May 01, 2024, 8:30 AM ET
Company Participants
Brian McKeon - Executive Vice President, Chief Financial Officer
Jay Mazelsky - President and Chief Executive Officer
Conference Call Participants
Chris Schott - JPMorgan
Nathan Rich - Goldman Sachs
Michael Ryskin - Bank of America
Erin Wright - Morgan Stanley
Jonathan Block - Stifel
Navann Ty - Exane BNP Paribas
Ryan Daniels - William Blair
Presentation
Operator
Good morning and welcome to the IDEXX Laboratories First Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay Mazelsky, President and Chief Executive Officer; Brian McKeon, Chief Financial Officer; and John Ravis, Vice President, Investor Relations.
IDEXX would like to preface the discussion today with a caution regarding forward-looking statements. Listeners are reminded that our discussion during the call will include forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those discussed today.
Additional information regarding these risks and uncertainties is available under the forward-looking statements noticed in our press release issued this morning, as well as in our periodic filings with the Securities and Exchange Commission, which can be attained from the SEC or by visiting the Investor Relations section of our website, idexx.com.
During this call, we will be discussing certain financial measures not prepared in accordance with generally accepted accounting principles, or GAAP. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures is provided in our earnings release, which may also be found by visiting the Investor Relations section of our website.
In reviewing our first quarter 2024 results and updated 2024 guidance, please note all references to growth, organic growth and comparable growth refer to growth compared to the equivalent prior year period, unless otherwise noted.
To allow broad participation in the Q&A, we ask that each participant limit their questions to one with one follow-up as necessary. We appreciate you may have additional questions, please feel free to get back into the queue and if time permits we will take your additional questions. Today's prepared remarks will be posted to idexx.com investors after the earnings conference call concludes....
IDEXX Laboratories, Inc. (IDXX) Q1 2024 Earnings Call Transcript